Danielle M. Lussier

MHC-II neoantigens shape tumour immunity and response to immunotherapy

Elise Alspach, Danielle M. Lussier, Alexander P. Miceli et al. · Nature · 2019 · 837 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Mhc-ii Neoantigens +6

Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma

Danielle M. Lussier, John L. Johnson, Pooja Hingorani et al. · Journal for ImmunoTherapy of Cancer · 2015 · 195 citations · Full text

Enhanced T-Cell Immunity to Osteosarcoma Through Antibody Blockade of PD-1/PD-L1 Interactions

Danielle M. Lussier, Lauren O’Neill, Lizbeth M. Nieves et al. · Journal of Immunotherapy · 2015 · 188 citations · Full text

Ctls Control, Tumor Immunology, Cancer Immunosurveillance +14

Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet

Danielle M. Lussier, Eric C. Woolf, John L. Johnson et al. · BMC Cancer · 2016 · 152 citations · Full text

Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads

Danielle M. Lussier, Elise Alspach, Jeffrey P. Ward et al. · Proceedings of the National Academy of Sciences · 2021 · 123 citations · Full text